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Contractility and Ventricular Systolic
Stiffening in Hypertensive Heart Disease
Insights Into the Pathogenesis of Heart Failure
With Preserved Ejection Fraction
Barry A. Borlaug, MD, Carolyn S. P. Lam, MBBS, Véronique L. Roger, MD, MPH,
Richard J. Rodeheffer, MD, Margaret M. Redfield, MD
Rochester, Minnesota
Objectives We sought to compare left ventricular (LV) systolic stiffness and contractility in normal subjects, hypertensive
patients without heart failure, and patients with heart failure and preserved ejection fraction (HFpEF) and to de-
termine whether LV systolic stiffness or myocardial contractility is associated with the rate of mortality in pa-
tients with HFpEF.
Background Arterial load is increased in patients with hypertension and is matched by increased end-systolic LV stiffness
(ventricular-arterial coupling). Increased end-systolic LV stiffness may be mediated by enhanced myocardial con-
tractility or processes that increase passive myocardial stiffness.
Methods Healthy control patients (n  617), hypertensive patients (no heart failure, n  719), and patients with HFpEF
(n  244, 96% hypertensive) underwent echo-Doppler characterization of arterial (Ea) and LV end-systolic (Ees)
stiffness (elastance), ventricular-arterial coupling (Ea/Ees ratio), and chamber-level and myocardial contractility
(stress-corrected midwall shortening).
Results We found that Ea and Ees were similarly increased in hypertensive patients with or without HFpEF compared
with control patients, but ventricular-arterial coupling was similar across groups. In hypertensive patients, in-
creased Ees was associated with enhanced chamber-level and myocardial contractility, whereas in patients with
HFpEF, chamber and myocardial contractility were depressed compared with both hypertensive and control pa-
tients. Group differences persisted after adjusting for geometry. In patients with HFpEF, impaired myocardial
contractility (but not Ees) was associated with increased age-adjusted mortality.
Conclusions Although arterial load is increased and matched by increased LV systolic stiffness in hypertensive patients
with or without HFpEF, the mechanisms of systolic LV stiffening differ substantially. These data suggest that
myocardial contractility increases to match arterial load in asymptomatic hypertensive heart disease, but
that progression to HFpEF may be mediated by processes that simultaneously impair myocardial contractil-
ity and increase passive myocardial stiffness. (J Am Coll Cardiol 2009;54:410–8) © 2009 by the
American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2009.05.013(
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tne-half of patients with heart failure (HF) have a preserved
jection fraction (i.e., heart failure with preserved ejection
raction [HFpEF]) (1–4). Heart failure with preserved ejection
raction predominantly afflicts elderly, hypertensive patients
1,3,4). Vascular stiffness increases with age, promoting systolic
ypertension and increased effective arterial elastance (Ea)
5,6). Left ventricular (LV) end-systolic stiffness (elastance)
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ccepted May 5, 2009.Ees) increases in tandem (5–7), such that the relationship
etween ventricular and arterial elastance (ventricular-arterial
oupling) remains relatively constant (8–10).
See page 419
End-systolic LV elastance is a measure of contractility, but
t is also influenced by chamber geometry and passive myocar-
ial stiffening (8,11). Ees is increased in patients with HFpEF
7,10), yet many studies (12–14), though not all (15), have
eported that various systolic function indices are mildly de-
ressed in patients with HFpEF. Indeed, it is well recognized
hat impairments in myocardial contractility may coexist with
reserved ejection fraction (EF) in hypertensive patients with
c
p
o
(
c
g
h
b
m
l
f
c
T
r
m
M
S
R
r
p
r
M
c
c
o
d
F
H
fi
t
C
o
a
O
d
d
a
p
p
a
E
s
s
t
(
u
2
s
d
t
(
a
e
a
b
s
p
p
p
t
s
e
w
v
A
b
d
(
d
d
w
b
a
b
a
l
c
d
b
f
d
r
t
A
c
c
d
e
s
d
m
e
i
s
b
d
(
a
c
m
u
p
S
b
p
r
a
411JACC Vol. 54, No. 5, 2009 Borlaug et al.
July 28, 2009:410–8 Contractility and LV Stiffness in HFpEFoncentric remodeling (16–20). This phenomenon allows the
reservation of endocardial motion despite reduced shortening
f individual myofibers, such that the EF remains normal
19,21).
We sought to compare and contrast chamber and myocardial
ontractility, LV Ees, and ventricular-arterial coupling in 3
roups, healthy control patients without cardiovascular disease,
ypertensive patients without HF, and patients with HFpEF,
y using multiple load-independent measures of chamber and
yocardial contractility. All participants were drawn from a
arge-scale, nonselected, population-based sample. To account
or differences in ventricular geometry, contractile indices were
ontrasted within each pattern of chronic chamber remodeling.
o determine the clinical significance of these findings, the
elationships between contractility or LV systolic stiffness and
ortality were examined.
ethods
tudy population and setting. The unique aspects of the
ochester Epidemiology Project for population-based
esearch have been described (2,3). The study was ap-
roved by the Mayo Institutional Review Board. A
andom sample (n  2,042) of the Olmsted County,
innesota, population age 45 years underwent echo-
ardiography and record review. From this cohort, 2
ontrol groups were identified (2,3,10): healthy, non-
bese control patients without cardiovascular disease or
iabetes, and hypertensive control patients without HF.
rom the same community, consecutive patients with
FpEF and no significant valvular disease were identi-
ed by use of the Framingham criteria (2,3). Vital status
hrough March 2008 was determined from the Mayo
linic registration database and the Rochester Epidemi-
logy Project death database (2,3). Mortality data were
scertained from medical records, death certificates for
lmsted County residents, obituaries, and notices of
eath in the local newspapers. Data on all Minnesota
eaths were obtained from the State of Minnesota
nnually. Some clinical characteristics and ventricular function
arameters from subjects in this study have previously been
ublished (1–3,10), but most of the systolic indices and their
ssociations with outcomes have not.
chocardiography. Comprehensive echocardiographic as-
essment was performed by registered diagnostic cardiac
onographers by the use of standardized instruments and
echniques, with studies interpreted in a blinded fashion
10). Ventricular dimensions, wall thickness, chamber vol-
mes, and stroke volume were determined in triplicate from
-dimensional, M-mode echocardiography, and Doppler
pectra with the use of standard methods (10). Sex-specific
efinitions for ventricular hypertrophy and geometry pat-
erns based on LV mass index and relative wall thickness
normal, concentric remodeling, concentric hypertrophy,
nd eccentric hypertrophy) were used (10). Left ventricular
nd-diastolic pressure was estimated from echo-Doppler pnd tissue-Doppler (10). Brachial
lood pressure was determined by
phygmomanometry. End-systolic
ressure was determined from the
roduct of: 0.9  systolic blood
ressure (8). Effective arterial elas-
ance (Ea  end-systolic pressure/
troke volume) and circumferential
nd-systolic wall stress (cESS)
ere determined as measures of
entricular afterload (8,19).
ssessment of LV systolic cham-
er and arterial properties. En-
ocardial fractional shortening
eFS) was determined from 2-
imensional systolic and diastolic
imensions. Left ventricular Ees
as determined by the single-
eat technique (22). Ventricular-
rterial interaction was quantified
y the coupling ratio (Ea/Ees). To
ccount for both afterload and pre-
oad, 2 additional load-independent measures of chamber
ontractility were examined: 1) wall-stress-corrected endocar-
ial fractional shortening (sc-eFS), which was determined
y expressing observed eFS as a percentage of that predicted
or any given wall stress, based upon the regression equation
erived in the healthy control patients (18); and 2) pre-load
ecruitable stroke work (PRSW), which was determined by
he use of a validated single-beat technique (23).
ssessment of myocardial contractility. Measures of
hamber-level contractility do not necessarily reflect myo-
ardial contractility (16–19,21) because motion at the en-
ocardial surface is greater than predicted by sarcomere short-
ning alone as the result of the phenomenon of cross-fiber
hortening. Shortening of muscle fibers oriented in orthogonal
irections at the inner and outer surfaces of the heart causes
arked thickening in the radial axis (21). This effect is
nhanced in the setting of concentric remodeling, allowing
ndividual reductions in myofiber contraction to achieve the
ame net displacement of endocardium, preserving endocardial-
ased parameters such as EF (16,18,19,21). To assess myocar-
ial contractility, circumferential midwall fractional shortening
mFS) was assessed by use of the 2-shell method of Shimizu
nd others (16–19). To minimize afterload dependence, stress-
orrected midwall fractional shortening (sc-mFS) was deter-
ined as a percentage of that predicted for any given wall stress
sing the regression equation derived from the healthy control
opulation (18).
tatistical methods. Categorical variables were compared
y the chi-square test, and continuous variables were com-
ared by the use of 1-way analysis of variance with Bonfer-
oni correction. Regression analysis was used to adjust for
ge, sex, body size, chamber size and morphology, or the
Abbreviations
and Acronyms
cESS  circumferential
end-systolic stress
Ea  effective arterial
elastance (stiffness)
Ees  end-systolic
elastance (stiffness)
EF  ejection fraction
HF  heart failure
HFpEF  heart failure with
preserved ejection fraction
LV  left ventricle
PRSW  pre-load
recruitable stroke work
sc-eFS  stress-corrected
endocardial fractional
shortening
sc-mFS  stress-corrected
midwall fractional
shorteningresence of other diseases, where the dependent variable was
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Contractility and LV Stiffness in HFpEF July 28, 2009:410–8he normally distributed continuous (linear least-squares
egression) or categorical (logistic regression) outcome vari-
ble of interest. Any interaction between these variables also
as evaluated and accounted for as appropriate. The Kaplan-
eier method tested for differences in survival between groups
y the log-rank test. Cox proportional-hazards regression was
sed to adjust for the effect of differences in baseline charac-
eristics on survival.
esults
ubject characteristics. Of 2,042 randomly selected com-
unity residents, 617 met the criteria for the healthy control
roup, and 719 subjects met the criteria for the hypertension
ithout HF group. A total of 244 patients constituted the
Subject CharacteristicsTable 1 Subject Characteristics
Demographics
Age (yrs)
Female (%)
Body mass index (kg/m2)
Hypertension (%)
Coronary artery disease (%)
Diabetes mellitus (%)
Estimated glomerular filtration rate (ml/min/1.73 m2)
Chronic beta-blocker use (%)
Hemodynamics and LV morphology
Systolic BP (mm Hg)
Diastolic BP (mm Hg)
LV mass index (g/m2)
Relative wall thickness
Percent with LV hypertrophy (%)
*p  0.05 versus control patients. †p  0.05 versus hypertensive pat
BP  blood pressure; HFpEF  heart failure with preserved ejection
Load, Contractility, and Ventricular-Arterial CoupTable 2 Load, Contractility, and Ventricular-
Control
(n 
LV afterload
cESS (kdyne/cm2) 90.8
Ea (mm Hg/ml) 1.30
Ventricular arterial coupling
Ees (mm Hg/ml) 1.99
Ea/Ees 0.68
Systolic function (%)
EF 63
eFS 39.7
mFS 20.9
Load-independent measures of contractility
PRSW (g/cm2) 84.5
sc-eFS (% of predicted) 100
sc-mFS (% of predicted) 100
*p  0.005 versus control patients. †p  0.0001 versus hypertensive
cESS  circumferential end-systolic stress; Ea  effective arteFS  endocardial fractional shortening; mFS  midwall fractional shorteni
other abbreviations as in Table 1.FpEF group. Nearly all patients with HFpEF had a
istory of hypertension and were older, more obese, and had
greater prevalence of coronary artery disease and diabetes
han hypertensive or control patients (Table 1).
entricular-arterial stiffness and coupling. Hypertensive
atients and patients with HFpEF displayed increased
fterload (Ea and cESS) compared with control patients
Table 2). Although Ea was similarly increased in hyper-
ensive patients and patients with HFpEF, cESS was
reater in patients with HFpEF. As previously reported
n this population (10), Ees was similarly increased in
ypertensive and HFpEF patients compared with control
atients (Table 2). Overall, Ees was strongly correlated with
a (Fig. 1A), and both this relationship and the mean
rol Patients
 617)
Hypertensive Patients
(n  719)
HFpEF Patients
(n  244)
(45–96) 66 (46–91)* 76 (22–99) *†
55 56 55
.4 2.7 29.8 5.9* 32.2 20.7*†
0 100* 96*
0 16* 53*†
0 11* 37*†
.4 14.1 74.7 37.0 64.3 28.1*†
2 29* 74*†
8 12 143 21* 132 23*†
0 8 76 11* 67 14†
.8 16.3 100.2 22.7* 102.1 29.0*
8 0.06 0.42 0.07* 0.45 0.10*†
18 40* 42*
n; LV  left ventricular.
ial Coupling
ts Hypertensive Patients
(n  719)
HFpEF Patients
(n  244)
98.9 28.5* 105.5 35.4*†
1.50 0.41* 1.53 0.43*
2.30 0.80* 2.42 0.90*
0.68 0.17 0.69 0.22
65 6 62 6*†
41.3 5.7* 35.9 6.6*†
21.5 2.7‡ 18.5 3.0*†
99.3 25.5* 78.7 31.1*†
108 11* 96 12*†
105 12* 91 13*†
ts (unadjusted).
lastance; Ees  end-systolic elastance; EF  ejection fraction;Cont
(n
57
25
74
11
7
88
0.3lingArter
Patien
617)
 21
 0.30
 0.59
 0.13
 5
 5.1
 2.5
 18.6
 8
 10
patien
erial eng; PRSW  pre-load recruitable stroke work; sc  stress-corrected;
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July 28, 2009:410–8 Contractility and LV Stiffness in HFpEFoupling ratios (Ea/Ees) were similar in all 3 groups (Table
), indicating preserved ventricular-arterial coupling.
eft ventricular chamber and myocardial systolic prop-
rties. As compared with control patients, EF was similar
ut eFS and mFS were greater in the hypertensive group. In
ontrast, in patients with HFpEF, EF, eFS, and mFS were
educed as compared with hypertensive or control patients
Table 2). Similarly, load-independent measures of chamber
ontractility (PRSW and sc-eFS) were greater in hyperten-
ive patients as compared with control patients and lower in
FpEF compared with hypertensive or control patients
Table 2, Fig. 1). Adjusting for wall stress (cESS), mFS was
reater in hypertensive patients compared with control
atients (Fig. 2A) and lower in patients with HFpEF
ompared with control patients (Fig. 2B) and hypertensive
atients (Fig. 2C). Patients with HFpEF displayed lower
c-mFS than hypertensive or control patients (Table 2, Fig.
), even after adjusting for age, sex, body size, renal
unction, beta-blocker use, history of coronary disease, and
iabetes (p  0.0001). The cumulative distribution of
c-mFS was shifted rightward from control patients in
ypertension and leftward in HFpEF (Fig. 2D), indicating
hat myocardial contractility was systematically enhanced in
ypertensive and impaired in HFpEF patients.
elationships of geometry to contractility. As previously
0 1 2 3 4
0
2
4
6
8 Control Hypertension HFpEF
r = 0.73, p<0.0001
Group p = 0.13
Ea (mmHg/ml)
Ee
s
(m
m
H
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m
l)
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100
125 *
sc
-e
FS
(%
)
A
C
Control Hypertension HFpEF
*
†
Figure 1 VA Coupling and Contractility
(A) The relationship between Ees and Ea was similar among each group (dashed
(PRSW and sc-eFS) and myocardial contractility (sc-mFS) were increased in hyperte
tensive and control patients. Data are mean  SD. *p  0.05 versus control; †p
elastance; eFS  endocardial fractional shortening; HFpEF  heart failure with
recruitable stroke work; sc  stress-corrected; VA  ventricular-arterial.escribed in this cohort (3,10), relative wall thickness Ancreased from control patients to hypertension to HFpEF
Table 1). The prevalence of LV hypertrophy was similarly
ncreased in hypertensive and HFpEF patients. The distri-
ution of geometry among hypertensives and HFpEF pa-
ients was different from that of control patients (Fig. 3A)
nd tended to be different in HFpEF versus hypertensive
atients (p  0.045).
In healthy control patients, Ees (Fig. 3B) and most
ontractile indices (Fig. 3C) were systematically elevated or
educed as a function of chamber geometry alone. To adjust
or confounding effects of chamber remodeling between the
roups, we compared Ees and each contractile index within
ach geometry pattern. Figure 4 shows that, regardless of
eometry, Ees was consistently increased in hypertensive
atients and patients with HFpEF as compared with
ontrol patients, whereas PRSW, sc-eFS, and sc-mFS were
ach consistently greater in hypertensive patients as com-
ared with control patients and lower in HFpEF as com-
ared with both hypertensive and control patients.
yocardial contractility and outcomes. Median follow-up
as 3.1 years (mean 3.1  0.6 years) in the HFpEF group.
ortality at 3 years was 36.4% in patients with HFpEF,
.1% in patients with hypertension, and 0.8% in control
atients. In the HFpEF group, survival decreased with
reater impairment of myocardial contractility (Fig. 5).
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how 95% prediction bands). (B to D) Load-independent chamber contractility
patients without HF and decreased in patients with HFpEF compared with hyper-
5 versus hypertension. Ea  effective arterial elastance; Ees  end-systolic
rved ejection fraction; mFS  midwall fractional shortening; PRSW  pre-loadD
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Contractility and LV Stiffness in HFpEF July 28, 2009:410–8ssociated with a 33% increase in mortality (p  0.013).
mpaired sc-mFS remained a significant predictor of mor-
ality after adjusting for age, body mass index, coronary
isease, hypertension, and diabetes mellitus (p  0.01). In
ontrast, EF, Ees, Ea, and geometry pattern were not
ssociated with age-adjusted mortality (p  0.05).
iscussion
his is the largest population-based study to date examining
V systolic properties in patients with HFpEF, exploring the
echanisms underlying ventricular-arterial coupling in hyper-
ensive heart disease according to the presence or absence of
FpEF. Among hypertensive patients, increases in end-
ystolic LV stiffness were associated with increased chamber
nd myocardial contractility. In contrast, similar increases in
FpEF patients were associated with impaired contractility,
uggesting that increased Ees may be related to passive myo-
ardial stiffening to a greater extent in this group. Disparities in
ontractile function were not due to differences in chamber
eometry, and impaired myocardial contractility in HFpEF
as associated with increased rates of mortality. We speculate
hat, over time, patients with hypertensive heart disease who
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HTNCON
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m
FS
 
(%
)
1.50 1.75 2.00 2.25 2.50
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HFpEFHTN
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m
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p<0.0001
p<0.0001
Figure 2 Myocardial Contractility
(A) The relationship between midwall myofiber shortening (mFS) and end-systolic w
(dotted line) in control patients (CON; black line) with data points and regression
myocardial contractility in hypertension. (B to C) In patients with HFpEF (red lines
(black line) and hypertensive (blue line) patients, indicating depressed contractili
patients (CON; black line), myocardial contractility is depressed in HFpEF (red line
in Figure 1.evelop HFpEF acquire structural or functional perturbations dhat impair myocardial contractility, and that these perturba-
ions contribute to the transition to and progression of overt
F, despite preserved EF.
entricular-arterial coupling. The interaction of the
eart with the arterial system (ventricular-arterial cou-
ling) is a key determinant of cardiovascular performance
8,9). Ea is a lumped parameter reflecting total arterial
fterload, incorporating mean and pulsatile components.
es is determined invasively from the slope and intercept
f the end-systolic pressure/volume relationship but may
lso be measured noninvasively (22), allowing Ees to be
etermined in larger patient populations. Ventricular-
rterial coupling is expressed by the Ea/Ees ratio (8).
Although EF is the most commonly used measure of
ystolic function in clinical practice, it is potently influenced
y loading conditions and chamber remodeling (24,25).
jection fraction is more accurately conceptualized as a
easure of ventricular-arterial coupling. Under normal
ircumstances, the Ea/Ees ratio varies from 0.5 to 1.0, a
ange in which cardiac work and efficiency are optimized
8,9). Although normal ventricular-arterial coupling ratios
and EF) were observed in each patient group, there were
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Cumulative distribution plot for sc-mFS show that compared with healthy control
enhanced in hypertensive patients without HF (HTN; blue line). Abbreviations asall str
line fo
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July 28, 2009:410–8 Contractility and LV Stiffness in HFpEFaintained—enhanced contractility in hypertensive pa-
ients without HF but impaired contractility in patients
ith HFpEF.
It is well recognized that changes in contractile perfor-
ance alter Ees (22,24), but Ees is also influenced by
hamber geometry and by factors that alter the passive
tiffness of the myocardium (8,11). With aging, increases in
*
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0
20
40
60
80
100
Normal Concentric Remodeling
Concentric Hypertrophy Eccentric Hypertrophy
p<0.0001 vs CON
**
%
B
Ees
1.5
2.0
2.5
3.0
*
*p<0.05 vs Normal Geometry
m
m
H
g/
m
l
C
PRSW sc - eFS sc - mFS
70
80
90
100
110
*
*
*
*
*
*
g/
cm
2
o
r 
%
*p<0.05 vs Normal Geometry
Figure 3 Geometry and Its Effect on
End-Systolic Elastance and Contractility Indexes
(A) The distributions of LV geometry differed among control, hypertensive, and
HFpEF patients. Even within the healthy control group, Ees varied according to
geometry pattern (B), as did PRSW, sc-eFS, and sc-mFS (C). See text for dis-
cussion. Data are mean  standard error. LV  left ventricular; other abbrevia-
tions as in Figures 1 and 2.rterial stiffness are associated with tandem increases in both iystolic and diastolic LV stiffness (5,6,8). Indeed, in this
tudy population, we have previously reported that diastolic
entricular stiffness is increased in both hypertensive and
FpEF patients compared with healthy control patients but
s greatest in patients with HFpEF (10). Taken together
ith the current findings of impaired contractility despite
ncreased Ees in patients with HFpEF, we speculate that the
rocesses that contribute to diastolic stiffening in HFpEF
nfluence systolic stiffness as well.
ontractility and coupling in patients with HFpEF. Semi-
al reports from the 1980s and 1990s (16–19,21) demon-
trated that abnormal myocardial contractility may coexist
ith a normal EF because concentric geometric chamber
emodeling preserves the extent of endocardial motion
elative to the diastolic cavity. A number of studies (12,26–29)
ave reported abnormalities in regional systolic function in
atients with HFpEF, particularly shortening in the longi-
udinal axis. However, the significance of these findings has
een questioned (30) because systolic velocities vary in-
ersely with afterload (31), typically increased in HFpEF
atients (8,10), and because longitudinal shortening does
ot fully reflect chamber-level contractility (30). By exam-
ning load-independent parameters of chamber and myo-
ardial contractility in a large, population-based study, we
how that patients with HFpEF indeed do display systolic
ysfunction compared with both hypertensive patients
ithout HF and healthy control patients.
The authors of 2 important but smaller-sized studies
14,15) also found that roughly one-third of patients with
FpEF were below the 95% prediction bands for the
elationship between mFS and cESS observed in healthy
ontrol patients. More important, 90% of patients with
FpEF fell below the mean regression line describing
ealthy control patients. This finding is consistent with the
ystematic shift in the distribution of myocardial contractil-
ty in HFpEF observed in the current study. However,
revious studies did not compare HFpEF with hypertensive
ontrol patients, HFpEF subjects were highly selected,
here were no adjustments for differences in LV geometry,
nd the impact of impaired myocardial contractility on
urvival was not examined (12,15,26–28).
Ees increases with decreasing LV size, yet even after
djusting for differences in geometry, Ees remained signifi-
antly increased in patients HFpEF, whereas each additional
oad-independent index of chamber-level and myocardial con-
ractility was impaired. This “disconnect” between Ees and
ther measures of contractility has been observed in animal
odels of pressure overload HF, where increased Ees coexists
ith impaired chamber, myocardial, and myocyte contractility;
brosis; diastolic dysfunction; and impaired beta-adrenergic
ignaling (32). The association of resting contractile dysfunc-
ion with increased mortality in patients with HFpEF, viewed
n light of these animal studies and recent studies demonstrat-
ng abnormal contractile reserve with stress in HFpEF (33–35),
ndicates that impaired contractility, however mild at rest,
m
r
o
C
H
H
H
t
g
s
t
w
w
h
s
t
(
t
f
o
s
t
(
c
T
t
t
s
c
(
p
t
n
I
u
l
p
t
m
p
m
S
f
416 Borlaug et al. JACC Vol. 54, No. 5, 2009
Contractility and LV Stiffness in HFpEF July 28, 2009:410–8ay not simply be an innocuous bystander in HFpEF but
ather may reflect processes that mediate progression to
vert HF.
ontractility and coupling in hypertension without HF.
ypertension is a dominant risk factor for patients with
FpEF (1,4), and many of the cardiovascular features in
FpEF are also found in asymptomatic hypertensive pa-
ients (13,33). As such, comparisons between these 2
roups provide valuable mechanistic insight into what
pecifically distinguishes the HFpEF phenotype. Al-
hough increased Ees in patients with HFpEF coexisted
ith impaired contractility, increased Ees was associated
ith enhanced contractility in hypertensives. Earlier studies
ave reported reduced myocardial contractility in hyperten-
ion, and that the presence of impaired myocardial contrac-
ility is associated with greater rates of cardiovascular events
13,16,18,19,36). However, the patient groups populating
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onclusions
lthough EF and ventricular-arterial coupling are similarly
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atch arterial load differs according to the presence of HF.
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